420 W. 12th Ave., Suite 514B
Columbus, Ohio 43210
Dr. Brasky is a member of the Cancer Control Program at the OSUCCC – James, where his research is centered on further understanding the link between inflammation and cancer.
Specifically, he studies how anti-inflammatory medications and nutrients with anti-inflammatory properties affect cancer occurrence, progression and survival. For example, his research has included the exploration of whether dietary intake of long-chain omega-3 fatty acids are associated with endometrial cancer risk, and separately, whether the use of non-steroidal anti-inflammatory drugs are associated with survival or recurrence from the disease.
Although recent projects focus on endometrial cancer, his interests are broad and include the study of many solid tumors, including cancers of the breast, prostate and lung, among others. Additionally, he is interested in the use of novel tobacco products and cannabis among cancer patients.
His team is presently recruiting patients into two studies related to this area. The first examines electronic cigarette use among patients who smoke and who are diagnosed with cancers of the head, neck and lung, while the second examines the use of cannabis and cannabis-based products among cancer patients at the OSUCCC – James.
He has authored or co-authored more than 80 peer-reviewed articles in impactful publications like Journal of Clinical Oncology, Journal of the National Cancer Institute, International Journal of Cancer, American Journal of Clinical Nutrition and American Journal of Epidemiology. He also sits on the editorial board of the journal Gynecologic Oncology and serves as associate editor for the journals Cancer Causes and Control and Contemporary Clinical Trials.
Return to People